UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035895 |
|---|---|
| Receipt number | R000040899 |
| Scientific Title | Effectiveness of using metabolomics in combination with MRI for liver metastasis from pancreatic cancer and biliary tract cancer |
| Date of disclosure of the study information | 2019/02/17 |
| Last modified on | 2019/08/18 12:09:42 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Effectiveness of using metabolomics in combination with MRI for liver metastasis from pancreatic cancer and biliary tract cancer
Acronym
Diagnosis of liver metastasis by MRI and metabolomics
Scientific Title
Effectiveness of using metabolomics in combination with MRI for liver metastasis from pancreatic cancer and biliary tract cancer
Scientific Title:Acronym
Diagnosis of liver metastasis by MRI and metabolomics
Region
| Japan |
Condition
Condition
Liver metastasis
Classification by specialty
| Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
We clarified radiological findings and the presene of low molecular weight metabolites in liver metastasis and evaluate whether diagnostic ability is improved by this integrated analysis as compared with the case of radiologial diagnosis alone.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
To identificate characteristic radiological findings and low molecular weight metabolites indicating the presence of metastatic liver tumor.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Diagnosis
Type of intervention
| Device,equipment |
Interventions/Control_1
Contrast enhanced MRI
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patient who was dagnosed or suspected pancreatic cancer or biliary tract cancer.
Patients who evaluate whether liver metastais is present using hepatocyte-specific MRI contrast agent Gd-EOB-DTPA.
Over 20 years old.
Key exclusion criteria
History of bronchial asthma
Renal dysfunction
Body contaminants(clips, stents, things embedded during orthopedic surgery)
Tattoo
Claustrophobia
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Kazuhiro |
| Middle name | |
| Last name | Saito |
Organization
Tokyo Medical University
Division name
Radiology
Zip code
160-0023
Address
6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo
TEL
03-3342-6111
saito-k@tokyo-med.ac.jp
Public contact
Name of contact person
| 1st name | Kazuhiro |
| Middle name | |
| Last name | Saito |
Organization
Tokyo Medical University
Division name
Radiology
Zip code
160-0023
Address
6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo
TEL
03-3342-6111
Homepage URL
saito-k@tokyo-med.ac.jp
Sponsor or person
Institute
Tokyo Medical University
Institute
Department
Personal name
Funding Source
Organization
Ministry of education
Organization
Division
Category of Funding Organization
Japanese Governmental office
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Center for Research Administration and Innovation, Tokyo Medical University
Address
6-7-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo
Tel
03-3342-6111
Adm_IRB@tokyo-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 02 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2018 | Year | 06 | Month | 20 | Day |
Date of IRB
| 2017 | Year | 05 | Month | 29 | Day |
Anticipated trial start date
| 2018 | Year | 09 | Month | 01 | Day |
Last follow-up date
| 2020 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2019 | Year | 02 | Month | 16 | Day |
Last modified on
| 2019 | Year | 08 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040899
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
